According to the new study, HIV achieves this with a tissue-specific approach, cloaking itself in a host cell's DNA by ...

Campaigners in Northern Ireland have called for the introduction of a 'game-changing' drug that will prevent HIV. On Friday ...

The UK has approved a long-acting injection for HIV prevention, administered every two months. Experts say it marks a major ...

South Africa has welcomed a U.S. bridging plan worth $115 million to continue funding HIV treatment and prevention programs ...

The southern Africa nation recently met the UNAids 95-95-95 fast-track targets, meaning that 95% of those living with HIV ...

Even as the medical care needed to treat patients with well-controlled HIV has been significantly streamlined, complex ...

The injection, known as cabotegravir, is a form of pre-exposure prophylaxis (PrEP) and is administered every two months.

In the wake of massive U.S. cuts to foreign aid, the tiny country of Lesotho in southern Africa faces deep uncertainty and ...

The UK's drugs cost-effectiveness watchdog has given a positive recommendation for ViiV Healthcare's HIV drug, enabling ...

South Africa's health minister has called lenacapavir, the first twice-yearly HIV prevention jab, a "groundbreaking" tool ...

The shot, given six times a year or every other month, is an alternative to taking daily pills to protect against ever ...

A long-acting injection designed to prevent HIV is set for approval in England and Wales. The cabotegravir (CAB-LA) treatment ...